SAFGEM

This brand name is authorized in Nigeria.

Active ingredients

The drug SAFGEM contains one active pharmaceutical ingredient (API):

1	Gemifloxacin UNII X4S9F8RL01 - GEMIFLOXACIN MESYLATE
	Gemifloxacin is a quinolone that has in vitro activity against a wide range of Gram-negative and Gram-positive microorganisms. Gemifloxacin acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV (TOPO IV), which are essential for bacterial growth.

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5448	Tablet	SAFGEM TABLET TAB 320 mg 1 X 7 Tablets	30 RNW-PP-170610 SAFGEM TABLET GEMIFLOXACIN 320mg List of Excipients: Avicel 102 Starch Lactose Primogel Aerosil 200 Magnesium stearate Isopropyl Alcohol Opadry White PEG 6000 B4-5448 Drugs Imported Products 1x7 Tablets Prescription Only Medicine (POM) 10/15/2020 NURUSHAT VENTURES LIMITED, FARAMOBI AJIKE STREET ANTHONY VILLAGE ANTHONY VILLAGE LAGOS 12347658 yomee_penners5@yahoo.com SAFFRON PHARMACEUTICALS (PVT) LTD, 19Km, Sheikhupura Road, Faisalabad-Pakistan, Pakistan	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA15	Gemifloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5448